MacroGenics, Inc.
MGNX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $73 | $22 | $13 | $18 |
| % Growth | 227.5% | 68.6% | -25.6% | – |
| Cost of Goods Sold | $13 | $9 | $5 | $5 |
| Gross Profit | $59 | $13 | $8 | $12 |
| % Margin | 81.6% | 60% | 59.1% | 69% |
| R&D Expenses | $33 | $41 | $40 | $39 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $10 | $9 | $11 | $28 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$2 | $0 | $0 | -$2 |
| Operating Expenses | $41 | $50 | $50 | $65 |
| Operating Income | $19 | -$37 | -$43 | -$53 |
| % Margin | 25.6% | -165.3% | -323.1% | -298% |
| Other Income/Exp. Net | -$2 | $1 | $2 | $38 |
| Pre-Tax Income | $17 | -$36 | -$41 | -$14 |
| Tax Expense | $0 | $0 | $0 | $1 |
| Net Income | $17 | -$36 | -$41 | -$15 |
| % Margin | 23.1% | -163% | -311.1% | -87% |
| EPS | 0.27 | -0.57 | -0.65 | -0.25 |
| % Growth | 147.4% | 12.3% | -160% | – |
| EPS Diluted | 0.27 | -0.57 | -0.65 | -0.25 |
| Weighted Avg Shares Out | 63 | 63 | 63 | 63 |
| Weighted Avg Shares Out Dil | 63 | 63 | 63 | 63 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $1 | $2 | $2 |
| Interest Expense | $3 | $1 | $0 | $0 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | $22 | -$33 | -$39 | -$12 |
| % Margin | 30.1% | -150.3% | -297% | -70.2% |